Hanmi Posts Record Sales in 2015
Hanmi Posts Record Sales in 2015
  • By Kim Min-ji (info@koreaittimes.com)
  • 승인 2016.02.05 10:49
  • 댓글 0
이 기사를 공유합니다

Hanmi Pharmaceutical posted record sales last year since its founding.

The local pharmaceutical company posted 1.3 trillion won in sales, a 73.1 percent increase from the previous year, alongside 211 billion won in operating profits and 162 billion won in net income, according to its regulatory filings on Thursday.

The strong sales came from the license fees with French multinational pharmaceutical company Sanofi and Belgium-based Janssen as well as sales from new products such as Rovelito, according to the firm.

Its investment in research and development stood at a total of 187 billion won as its project for the key new drug pipeline was transferred to a global partner company.

Although the investment volume rose by 22.7 percent, its investment rate compared to sales sharply rose to 14.2 percent.

The company's spokesperson said, "The company posted record sales thanks to the major license deals of its seven new drugs," adding, "We will continue this growth trend with continued R&D investment based on open innovation strategy."


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • ABOUT
  • CONTACT US
  • SIGN UP MEMBERSHIP
  • RSS
  • 2-D 678, National Assembly-daero, 36-gil, Yeongdeungpo-gu, Seoul, Korea (Postal code: 07257)
  • URL: www.koreaittimes.com | Editorial Div: 82-2-578- 0434 / 82-10-2442-9446 | North America Dept: 070-7008-0005 | Email: info@koreaittimes.com
  • Publisher and Editor in Chief: Monica Younsoo Chung | Chief Editorial Writer: Hyoung Joong Kim | Editor: Yeon Jin Jung
  • Juvenile Protection Manager: Choul Woong Yeon
  • Masthead: Korea IT Times. Copyright(C) Korea IT Times, All rights reserved.
ND소프트